Epileptiform EEG patterns induced by mirtazapine in both psychiatric patients and healthy volunteers [6]

Journal of Clinical Psychopharmacology

Volumn 23, Issue 4, 2003, Pages 421-422

  Juckel, Georg ^a   Schüle, Cornelius ^a   Pogarell, Oliver ^a   Rupp, Doris ^a   Laakmann, Gregor ^a   Hegerl, Ulrich ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOZAPINE; MIANSERIN; MIRTAZAPINE; PLACEBO; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR;

DEPRESSION; DROWSINESS; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; HUMAN; INCREASED APPETITE; LETTER; MONOTHERAPY; PRIORITY JOURNAL; SEDATION; THETA RHYTHM; WEIGHT GAIN; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; MENTAL DISORDERS; MIANSERIN;

EID: 0042634364     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000085422.74359.bb     Document Type: Letter

References (8)

1. de Boer T. The pharmacological profile of mirtazepine. J Clin Psychiatry. 1996;57(suppl 4):19-25.
2. Stimmel GL, Dopheide JA, Stahl SM. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects. Pharmacotherapy. 1997;17:10-21.
3. Montgomery SA. Safety of mirtazapine: a review. Int Clin Psychopharmacol. 1995;10(suppl 4):37-45.
4. Curran S, de Pauw K. Selecting an antidepressant for use in a patient with epilepsy - safety considerations. Drug Saf. 1998;18:125-133.
5. Laakmann G, Schüle C, Baghai T, et al. Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjects. Psychoneuroendocrinology. 1999;24:769-784.
6. Bridgers SL. Epileptiform abnormalities discovered on electroencephalographic screening of psychiatric inpatients. Arch Neurol. 1987;44:312-316.
7. Laakmann G, Schüle C, Baghai T, et al. Mirtazapine: an inhibitor of cortisol secretion that does not influence growth hormone and prolactin secretion. J Clin Psychopharmacol. 2000;20:101-103.
8. Richens A, Nawishy S, Trimble M. Antidepressant drugs, convulsions and epilepsy. Br J Clin Pharmacol. 1983;15(suppl 2):295S-298S.